title: Benefit of neuroprotection in acute ischaemic stroke, shall we dare to hope?
authors.affiliation: Stroke Service and Vascular Fellowship Program, International Cerebrovascular Translational Clinical Research Training Program (Fogarty International Center and National Institute of Neurologic Disorders and Stroke), Aga Khan University Hospital, Karachi, Pakistan.
authors.forename: Anjum
authors.initials: A
authors.lastname: Akhtar
authors.forename: Ayeesha Kamran
authors.initials: AK
authors.lastname: Kamal
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002545:Brain Ischemia / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D015220:Calcium Channels / Q000187:drug effects* / Q000378:metabolism; D005500:Follow-Up Studies; D036145:Ginsenosides / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007262:Infusions, Intravenous; D008875:Middle Aged; D005894:Panax; D020127:Recovery of Function; D020521:Stroke; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D015220:Calcium Channels; D036145:Ginsenosides; D000960:Hypolipidemic Agents; C048026:ginsenoside Rb2
references.citation: Eur J Neurol. 2012 Jun;19(6):855-63
references.pmid: 22233205